25 May 2013
Keywords: revia, launched, canada, alcoholism, dupont, pharma, its
Article | 29 January 1996
DuPont Pharma has launched its opioid receptor antagonist ReVia (naltrexone HCl) onto the market in Canada for the treatment of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.